Identification of biomarkers for tuberculosis disease using a novel dual-color RT-MLPA assay

Genes and Immunity

Volumn 13, Issue 1, 2012, Pages 71-82

  Joosten, S A ^a   Goeman, J J ^a   Sutherland, J S ^b   Opmeer, L ^a   De Boer, K G ^a   Jacobsen, M ^c,d   Kaufmann, S H E ^c   Finos, L ^a   Magis Escurra, C ^a,e   Ota, M O C ^b   Ottenhoff, T H M ^a   Haks, M C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

^c MAX PLANCK INSTITUTE FOR INFECTION BIOLOGY   (Germany)

^d BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

^e Nijmegen University Medical Center Dekkerswald   (Netherlands)

Author keywords

dcRT MLPA; host biomarkers; tuberculosis

Indexed keywords

BIOLOGICAL MARKER;

ACCURACY; ADAPTIVE IMMUNITY; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DUAL COLOR REVERSE TRANSCRIPTASE MULTIPLEX LIGATION DEPENDENT AMPLIFICATION; GENETIC TRANSCRIPTION; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN CELL; IMMUNE RESPONSE; MULTIPLEX LIGATION DEPENDENT PROBE AMPLIFICATION; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SENSITIVITY ANALYSIS; T LYMPHOCYTE; TUBERCULOSIS;

GENE EXPRESSION PROFILING; GENETIC MARKERS; HUMANS; NUCLEIC ACID AMPLIFICATION TECHNIQUES; REAL-TIME POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84855968010     PISSN: 14664879     EISSN: 14765470     Source Type: Journal    
DOI: 10.1038/gene.2011.64     Document Type: Article

References (27)

1. Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF et al. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69: 89-95. (Pubitemid 32225406)
2. Bowtell DD. Options available-from start to finish-for obtaining expression data by microarray. Nat Genet 1999; 21: 25-32. (Pubitemid 29031488)
3. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, Glaziou P et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010; 375: 1814-1829.
4. World Health Organization. Global tuberculosis control epidemiology, strategy, financing. WHO Report,WHO, Geneva 2009.
5. Kaufmann SH. Future vaccination strategies against tuberculosis: thinking outside the box. Immunity 2010; 33: 567-577.
6. Schouten JP, McElgunn CJ, Waaijer R, Zwijnenburg D, Diepvens F, Pals G. Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification. Nucleic Acids Res 2002; 30: e57.
7. Eldering E, Spek CA, Aberson HL, Grummels A, Derks IA, de Vos AF et al. Expression profiling via novel multiplex assay allows rapid assessment of gene regulation in defined signalling pathways. Nucleic Acids Res 2003; 31: e153.
8. White SJ, Vink GR, Kriek M, Wuyts W, Schouten J, Bakker B et al. Two-color multiplex ligation-dependent probe amplification: detecting genomic rearrangements in hereditary multiple exostoses. Hum Mutat 2004; 24: 86-92. (Pubitemid 38859227)
9. Bonecini-Almeida MG, Ho JL, Boechat N, Huard RC, Chitale S, Doo H et al. Down-modulation of lung immune responses by interleukin-10 and transforming growth factor beta (TGF-beta) and analysis of TGF-beta receptors I and II in active tuberculosis. Infect Immun 2004; 72: 2628-2634. (Pubitemid 38542389)
10. Demissie A, Abebe M, Aseffa A, Rook G, Fletcher H, Zumla A et al. Healthy individuals that control a latent infection with Mycobacterium tuberculosis express high levels of Th1 cytokines and the IL-4 antagonist IL-4delta2. J Immunol 2004; 172: 6938-6943. (Pubitemid 38669133)
11. Knudsen TB, Gustafson P, Kronborg G, Kristiansen TB, Moestrup SK, Nielsen JO et al. Predictive value of soluble haemoglobin scavenger receptor CD163 serum levels for survival in verified tuberculosis patients. Clin Microbiol Infect 2005; 11: 730-735. (Pubitemid 41167339)
12. Lienhardt C, Azzurri A, Amedei A, Fielding K, Sillah J, Sow OY et al. Active tuberculosis in Africa is associated with reduced Th1 and increased Th2 activity in vivo. Eur J Immunol 2002; 32: 1605-1613. (Pubitemid 34679148)
13. Jacobsen M, Repsilber D, Gutschmidt A, Neher A, Feldmann K, Mollenkopf HJ et al. Candidate biomarkers for discrimination between infection and disease caused by Mycobacterium tuberculosis. J Mol Med 2007; 85: 613-621. (Pubitemid 46876510)
14. Abebe M, Doherty TM, Wassie L, Aseffa A, Bobosha K, Demissie A et al. Expression of apoptosis-related genes in an Ethiopian cohort study correlates with tuberculosis clinical status. Eur J Immunol 2010; 40: 291-301.
15. Tibshirani R. Regression shrinkage and selection via the lasso. J Royal Statist Soc B 1996; 58: 267-288.
16. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T et al. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 2010; 466: 973-977.
17. Jenner RG, Young RA. Insights into host responses against pathogens from transcriptional profiling. Nat Rev Microbiol 2005; 3: 281-294. (Pubitemid 40443722)
18. Mistry R, Cliff JM, Clayton CL, Beyers N, Mohamed YS, Wilson PA et al. Gene-expression patterns in whole blood identify subjects at risk for recurrent tuberculosis. J Infect Dis 2007; 195: 357-365. (Pubitemid 46146113)
19. Maertzdorf J, Repsilber D, Parida SK, Stanley K, Roberts T, Black G et al. Human gene expression profiles of susceptibility and resistance in tuberculosis. Genes Immun 2011; 12: 15-22.
20. Abebe F, Bjune G. The protective role of antibody responses during Mycobacterium tuberculosis infection. Clin Exp Immunol 2009; 157: 235-243.
21. Cooper AM. Cell-mediated immune responses in tuberculosis. Annu Rev Immunol 2009; 27: 393-422.
22. Burl S, Hill PC, Jeffries DJ, Holland MJ, Fox A, Lugos MD et al. FOXP3 gene expression in a tuberculosis case contact study. Clin Exp Immunol 2007; 149: 117-122. (Pubitemid 46897109)
23. Shafiani S, Tucker-Heard G, Kariyone A, Takatsu K, Urdahl KB. Pathogen-specific regulatory T cells delay the arrival of effector Tcells in the lung during early tuberculosis. J Exp Med 2010; 207: 1409-1420.
24. Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science 2008; 320: 1220-1224. (Pubitemid 351929511)
25. Searle SR, Casella GM, McCulloch CE. Variance components. Wiley-Interscience 1992.
26. Goeman JJ, Solari A. The sequential rejection principle of familywise error control. Ann Statist 2010; 38: 3782-3810.
27. Meinshausen N. Hierarchical testing of variable importance. Biometrika 2008; 95: 265-278. (Pubitemid 351797208)